InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Nikhil Lalwani, PRESIDENT & CEO, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 9 open-market SEC Form 4 transactions: 1 purchase worth $200K and 8 sales worth $19.0M, reported from Mar 21, 22 to May 11, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 11, 26 | ANIPANI PHARMACEUTICALS INC | SELL | 55.0K | $77.57 | $4.3M |
| Aug 12, 25 | ANIPANI PHARMACEUTICALS INC | SELL | 57.0K | $85.93 | $4.9M |
| Nov 26, 24 | ANIPANI PHARMACEUTICALS INC | SELL | 30.0K | $58.30 | $1.7M |
| May 14, 24 | ANIPANI PHARMACEUTICALS INC | SELL | 16.7K | $66.10 | $1.1M |
| Mar 8, 24 | ANIPANI PHARMACEUTICALS INC | SELL | 16.3K | $67.13 | $1.1M |
| Mar 6, 24 | ANIPANI PHARMACEUTICALS INC | SELL | 29.0K | $65.52 | $1.9M |
| Aug 15, 23 | ANIPANI PHARMACEUTICALS INC | SELL | 11.6K | $61.13 | $710K |
| Aug 11, 23 | ANIPANI PHARMACEUTICALS INC | SELL | 56.7K | $57.75 | $3.3M |
| Mar 21, 22 | ANIPANI PHARMACEUTICALS INC | BUY | 7.2K | $27.69 | $200K |